MedTrace Logo

Exercise and/or HMB in Older Diabetes With Low Muscle Mass

NCT07142941 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-03-31

No results posted yet for this study

Summary

The investigators aimed to examine if β-hydroxy-β-methylbutyrate (HMB) supplementation enhances the effects of exercise on muscle mass, physical performance and insulin resistance and observe potential residual effects in older diabetes with low muscle mass, and to find the optimal treatment plan.

Conditions

Interventions

DIETARY_SUPPLEMENT

HMB

Participants were instructed to take active products including 3000 mg calcium-HMB per day

BEHAVIORAL

Exercise

Participants allocated to the exercise programs were provided 45 min of supervised sessions on 2 nonconsecutive days per week

DIETARY_SUPPLEMENT

Placebo

Participants were instructed to take active products including equal in quality resistant dextrin per day

OTHER

Education

Participants were given health education and educational manuals

Sponsors & Collaborators

  • Wu Shangling

    lead OTHER

Principal Investigators

  • Shangling Wu · First Affiliated Hospital, Sun Yat-Sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07142941 on ClinicalTrials.gov